Products for Research Use Only
RegisterLogin

Mofezolac

CAT: 0804-HY-120824-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-120824-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Mofezolac, a non-steroidal anti-inflammatory drug (NSAID), is a selective, reversible and orally active COX-1 inhibitor with an IC50 of 1.44 nM. Mofezolac shows weak inhibitory activity on COX-2 (IC50 of 447 nM) . Mofezolac can relieve pain and has anti-inflammatory activities[1].
CAS Number
78967-07-4
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
COX
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mofezolac.html
Concentration
10mM
Purity
99.34
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)CC1=C(C2=CC=C(OC)C=C2)C(C3=CC=C(OC)C=C3)=NO1
Molecular Formula
C19H17NO5
Molecular Weight
339.34
Precautions
H302, H315, H319, H335
References & Citations
[1]K Goto, et al. Analgesic effect of mofezolac, a non-steroidal anti-inflammatory drug, against phenylquinone-induced acute pain in mice. Prostaglandins Other Lipid Mediat. 1998 Jul;56 (4) :245-54.|[2]Maria Laura Pati, et al. Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability. Eur J Med Chem. 2019 Feb 15;164:59-76.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
COX-1; COX-2

Alternative Products

CatalogName
BA5923-5Mofezolac
A22681-5Mofezolac 5mg
A22681-200Mofezolac 200mg
A22681-50Mofezolac 50mg
A22681-25Mofezolac 25mg
A22681-100Mofezolac 100mg
A22681-10Mofezolac 10mg
A22681-10mM-DMofezolac 10mM * 1mL in DMSO

Popular Products